Anti-FXa Activity with Intermediate-Dose Thromboprophylaxis in COVID-19 Reply

Dutt, Tina, Simcox, David, Downey, Colin, McLenaghan, Daniella, King, Charlotte ORCID: 0000-0002-7887-3640, Gautam, Manish, Lane, Steven and Burhan, Hassan (2020) Anti-FXa Activity with Intermediate-Dose Thromboprophylaxis in COVID-19 Reply. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 202 (12). pp. 1733-1734.

PDF Reply to Rappaport iet al.i Anti-FXa Activity with Intermediate-Dose Thromboprophylaxis in COVID-19.pdf - Unspecified Download (527kB) | Preview

Abstract

Dutt T, Simcox D, Downey C, McLenaghan, D, King, C, Gautam, M, Lane, S, Burhan, H, Thromboprophylaxis in COVID-19: Anti-FXa - The Missing Factor? [published online ahead of print, 2020 Jun 8]. Am J Respir Crit Care Med. 2020;10.1164/rccm.202005-1654LE. doi:10.1164/rccm.202005-1654LE.

Item Type:	Article
Uncontrolled Keywords:	Humans, Anticoagulants, Drug Monitoring, Venous Thromboembolism, COVID-19, SARS-CoV-2
Divisions:	Faculty of Health and Life Sciences Faculty of Health and Life Sciences > Institute of Population Health Faculty of Health and Life Sciences > Clinical Directorate
Depositing User:	Symplectic Admin
Date Deposited:	11 Oct 2022 09:31
Last Modified:	17 Mar 2024 09:48
DOI:	10.1164/rccm.202007-2913LE
Related URLs:	Author Publisher
URI:	https://livrepository.liverpool.ac.uk/id/eprint/3165322